Advances in alternative pharmacotherapy of ADHD
Pityaratstian, N.
Journal of the Medical Association of Thailand 88(Suppl 4): S357-S362
2005
ISSN/ISBN: 0125-2208 PMID: 16623055 Document Number: 8219
Several alternatives to psychostimulants have been developed and expanded the variability of the treatment of ADHD. Clonidine is a good option for managing core behavioral symptoms, especially hyperactivity and impulsivity. Bupropion and venlafaxine seem potentially promising. Significant new options include norepinephrine reuptake inhibitors, such as atomoxetine, and possibly selective dopamine agonists. Central anticholinesterases, such as donepezil, may improve core ADHD symptoms.